Medplus Health Services Share Price Today (MEDPLUS)
TODAY IN ONE LINE
MEDPLUS is little changed at ₹718.85 on average volume — a quiet consolidation day, supported by recent strong earnings.
With a market cap of ₹8,595.81 Cr., it trades at a P/E of 41.13. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Medplus Health Services flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 24.1% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 23.5% and Profit up 24.6%
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.01x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest Medplus Health Services News
What changed recently?
Recent events, corporate actions, and announcements.
Medplus Health Services Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Medplus Health Services Limited, framed against the sector median so the premium or discount is obvious at a glance.
Medplus Health Services Limited trades at a P/E of 41.13× and P/B of 4.39×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Medplus Health Services Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Medplus Health Services Limited — derived from the live tape, not yesterday's close.
Medplus Health Services Limited last traded at ₹718.85 with an intraday range of ₹710–₹724 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹718.85| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 753.23 | +34.38 | +4.78% |
| R3 | 739.23 | +20.38 | +2.84% |
| R2 | 731.62 | +12.77 | +1.78% |
| R1 | 725.23 | +6.38 | +0.89% |
| PIVOT | 717.62 | -1.23 | -0.17% |
| CURRENT | 718.85 | — | — |
| S1 | 711.23 | -7.62 | -1.06% |
| S2 | 703.62 | -15.23 | -2.12% |
| S3 | 697.23 | -21.62 | -3.01% |
| S4 | 683.23 | -35.62 | -4.95% |
MEDPLUS is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹712.2–₹723.25
Trading Inside opening range
Medplus Health Services Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Medplus Health Services Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Medplus Health Services Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹8,595.81 Cr. and reported EPS of ₹18.28.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 6,136 | 6,892 ▲ 12.3% |
| Sales Growth YoY %Derived | 9.09% | 12.33% |
| Other Income | 49 | 71 ▲ 46.7% |
| Total Income | 6,185 | 6,964 ▲ 12.6% |
| 4,641 | 5,085 ▲ 9.6% | |
| Gross ProfitDerived | 1,495 | 1,808 ▲ 20.9% |
| Gross Margin %Derived | 24.37% | 26.23% |
| 1,008 | 1,200 ▲ 19.1% | |
| EBITDA (Operating Profit)Derived | 487 | 607 ▲ 24.7% |
| OPM %Derived | 7.94% | 8.81% |
| 352 | 403 ▲ 14.5% | |
| Profit Before Tax (PBT) | 183 | 275 ▲ 50.2% |
| 33 | 56 ▲ 68.6% | |
| Effective Tax %Derived | 18.03% | 20.24% |
| Total Profit for Period | 150 | 220 ▲ 46.2% |
| Less: Non-controlling Interests | -0 | -0 ▲ 51.7% |
| Net Profit (Owner's PAT)Derived | 150 | 220 ▲ 46.1% |
| Net Profit Margin %Derived | 2.45% | 3.19% |
| PAT Growth YoY %Derived | 129.59% | 46.12% |
| Earnings Per Share (EPS ₹) | 12.56 | 18.30 ▲ 45.7% |
| Diluted Shares Outstanding (Cr) | 12 | 12 ▲ 0.3% |
| Other Comprehensive Income (Net of Tax) | 0 | 2 ▲ 1387.0% |
| Total Expenses (incl. D&A & Interest) | 6,001 | 6,688 ▲ 11.4% |
| Material Cost % of RevenueDerived | 1.01% | 1.29% |
| Employee Cost % of RevenueDerived | 11.83% | 12.83% |
| Other Cost % of RevenueDerived | 4.60% | 4.58% |
| Interest Coverage (x)Derived | 2.31x | 2.69x |
| Period | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|
| Revenue from Operations | 3,779 | 4,558 ▲ 20.6% | 5,625 ▲ 23.4% | 6,136 ▲ 9.1% | 6,892 ▲ 12.3% | |
| Sales Growth YoY %Derived | — | 20.59% | 23.42% | 9.09% | 12.33% | |
| Other Income | 31 | 46 ▲ 46.9% | 40 ▼ 13.2% | 49 ▲ 21.5% | 71 ▲ 46.7% | |
| Total Income | 3,811 | 4,604 ▲ 20.8% | 5,665 ▲ 23.1% | 6,185 ▲ 9.2% | 6,964 ▲ 12.6% | |
2,982 | 3,558 ▲ 19.3% | 4,392 ▲ 23.4% | 4,641 ▲ 5.7% | 5,085 ▲ 9.6% | ||
| Gross ProfitDerived | 797 | 1,000 ▲ 25.5% | 1,233 ▲ 23.3% | 1,495 ▲ 21.3% | 1,808 ▲ 20.9% | |
| Gross Margin %Derived | 21.09% | 21.94% | 21.92% | 24.37% | 26.23% | |
525 | 734 ▲ 40.0% | 879 ▲ 19.7% | 1,008 ▲ 14.7% | 1,200 ▲ 19.1% | ||
| EBITDA (Operating Profit)Derived | 272 | 266 ▼ 2.5% | 354 ▲ 33.3% | 487 ▲ 37.6% | 607 ▲ 24.7% | |
| OPM %Derived | 7.21% | 5.83% | 6.29% | 7.94% | 8.81% | |
186 | 265 ▲ 42.4% | 321 ▲ 21.2% | 352 ▲ 9.9% | 403 ▲ 14.5% | ||
| Profit Before Tax (PBT) | 118 | 47 ▼ 60.0% | 73 ▲ 55.7% | 183 ▲ 149.6% | 275 ▲ 50.2% | |
23 | -3 ▼ 112.7% | 8 ▲ 367.4% | 33 ▲ 320.2% | 56 ▲ 68.6% | ||
| Effective Tax %Derived | 19.69% | -6.24% | 10.71% | 18.03% | 20.24% | |
| Total Profit for Period | 95 | 50 ▼ 47.1% | 66 ▲ 30.9% | 150 ▲ 129.1% | 220 ▲ 46.2% | |
| Less: Non-controlling Interests | -1 | 0 ▲ 131.5% | 0 ▼ 69.6% | -0 ▼ 185.6% | -0 ▲ 51.7% | |
| Net Profit (Owner's PAT)Derived | 96 | 50 ▼ 48.1% | 65 ▲ 31.6% | 150 ▲ 129.6% | 220 ▲ 46.1% | |
| Net Profit Margin %Derived | 2.53% | 1.09% | 1.16% | 2.45% | 3.19% | |
| PAT Growth YoY %Derived | — | -48.06% | 31.57% | 129.59% | 46.12% | |
| Earnings Per Share (EPS ₹) | 8.03 | 4.17 ▼ 48.1% | 5.48 ▲ 31.4% | 12.56 ▲ 129.2% | 18.30 ▲ 45.7% | |
| Diluted Shares Outstanding (Cr) | 12 | 12 ▲ 0.0% | 12 ▲ 0.2% | 12 ▲ 0.1% | 12 ▲ 0.3% | |
| Other Comprehensive Income (Net of Tax) | 2 | 0 ▼ 81.7% | -0 ▼ 116.5% | 0 ▲ 365.5% | 2 ▲ 1387.0% | |
| Total Expenses (incl. D&A & Interest) | 3,693 | 4,556 ▲ 23.4% | 5,591 ▲ 22.7% | 6,001 ▲ 7.3% | 6,688 ▲ 11.4% | |
| Material Cost % of RevenueDerived | 0.51% | 0.57% | 0.79% | 1.01% | 1.29% | |
| Employee Cost % of RevenueDerived | 10.42% | 11.96% | 11.12% | 11.83% | 12.83% | |
| Other Cost % of RevenueDerived | 3.46% | 4.15% | 4.51% | 4.60% | 4.58% | |
| Interest Coverage (x)Derived | 2.30x | 1.01x | 1.35x | 2.31x | 2.69x |
Medplus Health Services segment analysis : revenue and profit mix.
Disclosed business segments at Medplus Health Services with their share of revenue and profit, switchable between consolidated and standalone reporting.
Medplus Health Services discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Medplus Health Services Limited.
Our AI distills the core fundamental drivers supporting Medplus Health Services Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Medplus Health Services Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Latest quarterly EPS grew 24.6% YoY, demonstrating robust earnings momentum despite premium valuation
TTM revenue grew 23.5% YoY with net profit surging 55.1% in FY2026, indicating strong profitability acceleration
Operating margin 4.71% TTM exceeds peer Entero's 3.38%, signaling superior cost management in retail pharmacy
Debt-to-equity 0.0072x with fortress balance sheet, zero financial distress risk, and negative net debt position
Market cap ₹9.81 lakh Cr — nearly 1.9x larger than peer Entero — commands market leadership and scale advantages
Key Risks.
P/E ratio 44.68x signals premium valuation relative to earnings growth trajectory and forward P/E 32.62x
Net profit margin 3.21% TTM remains thin despite revenue acceleration, limiting profitability cushion
ROCE 12.60% below typical cost of capital, questioning capital deployment efficiency and returns
Zero dividend yield offers no income for dividend-seeking investors despite strong cash generation
Quarterly sales growth 3.61% lags TTM growth 23.5%, signaling potential deceleration in near-term momentum
Flip Conditions.
Valuation risk. a P/E above 53 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.22. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Medplus Health Services Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Medplus Health Services Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Medplus Health Services Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Medplus Health Services Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Medplus Health Services Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Medplus Health Services Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Medplus Health Services Limited stood at 58.5% of traded volume, against a 20-day average of 54.7%.
Medplus Health Services announcements: results, concalls, ratings, M&A.
Filings Medplus Health Services sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Medplus Health Services files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 288 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Medplus Health Services Limited has informed the Exchange about Transcript
Copy of Newspaper Publication
Newspaper Publication for completion of dispatch of Notice of 20th Annual General Meeting
General Updates
MEDPLUS: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations,…
Updates
Business Responsibility and Sustainability Report for the Financial Year 2025-26
Shareholders meeting
Notice of 20th Annual General Meeting of the Company for the Financial Year 2025-26
Investor decks & rating reports.
Medplus Health Services dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Medplus Health Services has declared, sequenced by announce and record date.
Medplus Health Services corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
Medplus Health Services insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Medplus Health Services as reported to SEBI — buying and selling signals from the people who know the business best.
Medplus Health Services insider activity below tracks 4 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Lone Furrow Investment Private Limited | Insider | 02 Jan 2025 | buy | +5.00 L | ₹41.59 Cr. | ₹831.75 |
| MADHUKAR REDDY GANGADI | Insider | 31 Dec 2024 | buy | +19.18 L | ₹162.49 Cr. | ₹847.20 |
| Lone Furrow Investment Private Limited | Insider | 27 Dec 2024 | buy | +1.54 Cr | ₹1,288.56 Cr. | ₹839.15 |
| MADHUKAR REDDY GANGADI | Insider | 23 Dec 2024 | buy | +1.34 Cr | ₹1,162.91 Cr. | ₹865.75 |
About Medplus Health Services Limited: business, sector, key facts.
What Medplus Health Services Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Medplus Health Services Limited operates in the Pharmacy Retail industry under the Consumer Services sector, listed as NSE: MEDPLUS, BSE: 543427.
MedPlus Health Services Limited is a prominent Indian company primarily engaged in the retail sale of pharmaceuticals and a wide range of related products. Their business model centers around a vast network of physical stores strategically located across several key Indian states, including Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West Bengal, Maharashtra, Orissa, Madhya Pradesh, Chhattisgarh, Kerala, and Puducherry. This extensive physical presence allows them to reach a large customer base and offer convenient access to essential healthcare items.
Beyond retail sales, MedPlus has diversified its operations to include the manufacturing and trading of both pharmaceutical and wellness products. This encompasses a substantial portfolio, ranging from prescription medications and vitamins to medical devices and diagnostic test kits. The company's product line also extends into the consumer goods sector, with a focus on home and personal care items such as toiletries, baby care products, soaps, detergents, and sanitizers. This diversification strengthens their market position and allows them to cater to a broader range of consumer needs within the health and wellness space.
Further expanding their reach and services, MedPlus operates a robust wholesale cash-and-carry business, supplying pharmaceuticals and related goods to other businesses and healthcare providers. In addition to retail and wholesale, MedPlus offers a range of healthcare services including diagnostic, pathological, and laboratory testing services. This integrated approach to healthcare allows them to provide a comprehensive suite of offerings under a single brand, enhancing customer convenience and loyalty.
The company also undertakes contract manufacturing of private label pharmaceuticals for other companies, demonstrating their capabilities in production and supply chain management. The addition of an online platform complements their physical store network, enhancing accessibility and reach to customers across various geographical locations. In summary, MedPlus' business model is characterized by a strategic combination of retail sales, manufacturing, wholesale distribution, healthcare services, and an online presence, solidifying its position as a significant player in India's healthcare market.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
Questions investors ask about Medplus Health Services Limited (MEDPLUS).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Medplus Health Services Limited (MEDPLUS)?
The current share price of Medplus Health Services Limited (MEDPLUS) is ₹718.85. Today, the stock has declined by ₹1.70 (0.24%), trading in a range of ₹710 to ₹724. The stock opened at ₹720.95 with a trading volume of 2,80,454 shares.
02Is Medplus Health Services Limited stock a good investment for long-term?
Medplus Health Services Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹8,595.81 crores, P/E ratio of 41.13, ROE of 11.80%, and ROCE of 12.60%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Medplus Health Services Limited stock?
The 52-week high price of Medplus Health Services Limited (MEDPLUS) is ₹1,022.2, while the 52-week low is ₹653. Currently trading at ₹718.85, the stock is 17.8% away from its 52-week low and 29.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Medplus Health Services Limited stock at the current price?
Whether to buy Medplus Health Services Limited stock at ₹718.85 depends on multiple factors. The stock is currently trading with a P/E ratio of 41.13 and P/B ratio of 4.39. Today's performance shows a loss of 0.24%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Medplus Health Services Limited and when is the next dividend?
Medplus Health Services Limited offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹718.85, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Medplus Health Services Limited?
Medplus Health Services Limited's key financial metrics include: P/E Ratio: 41.13, P/B Ratio: 4.39, ROE: 11.80%, ROCE: 12.60%, Dividend Yield: 0.00%, EPS: ₹18.28, Book Value: ₹164.55, and Debt-to-Equity: 0.72. The company's market cap stands at ₹8,595.81 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Medplus Health Services Limited stock performing today in the market?
Medplus Health Services Limited stock opened at ₹720.95 and is currently trading at ₹718.85, showing a decline of ₹1.70 (0.24%). The intraday high is ₹724 and low is ₹710. The trading volume stands at 2,80,454 shares, indicating moderate market participation today.
08What is the P/E ratio of Medplus Health Services Limited and what does it indicate?
Medplus Health Services Limited has a Price-to-Earnings (P/E) ratio of 41.13, which means investors are willing to pay ₹41.13 for every ₹1 of earnings. With an EPS of ₹18.28, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Medplus Health Services Limited (MEDPLUS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.